EP1547587A4 — Agent for reducing side effects of diclofenac
Assigned to Ono Pharmaceutical Co Ltd · Expires 2009-04-08 · 17y expired
What this patent protects
Reduction of the side effects of diclofenac or its salt. An agent for reducing the side effects of diclofenac or its salt characterized by containing ornoprostil. It is expected that a composition containing diclofenac or its nontoxic salt with ornoprostil is comparable or even s…
USPTO Abstract
Reduction of the side effects of diclofenac or its salt. An agent for reducing the side effects of diclofenac or its salt characterized by containing ornoprostil. It is expected that a composition containing diclofenac or its nontoxic salt with ornoprostil is comparable or even superior to marketed diclofenac tablets or arthrotec tablets in effects and immediate action while showing little side effects (in particular, digestive disorder, gastric ulcer, diarrhea/vomiting and renal disorder) and exerting excellent antipyretic, analgesic and antiinflammatory effects. By formulating the composition into a preparation of separate package type, the stability of ornoprostil can be improved.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.